Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 97.09 Million USD | -6.05% |
| 2022 | 103.34 Million USD | -0.66% |
| 2021 | 104.03 Million USD | 16.82% |
| 2020 | 89.06 Million USD | 11.85% |
| 2019 | 79.62 Million USD | 5.18% |
| 2018 | 75.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 22.67 Million USD | 0.0% |
| 2024 Q1 | 22.67 Million USD | -7.29% |
| 2023 Q4 | 24.45 Million USD | 0.0% |
| 2023 Q1 | 24.09 Million USD | -50.33% |
| 2023 FY | 97.09 Million USD | -6.05% |
| 2023 Q3 | 24.45 Million USD | -49.25% |
| 2023 Q2 | 48.19 Million USD | 100.0% |
| 2022 Q2 | 54.83 Million USD | 100.0% |
| 2022 FY | 103.34 Million USD | -0.66% |
| 2022 Q1 | 27.41 Million USD | -1.52% |
| 2022 Q4 | 48.51 Million USD | 100.0% |
| 2022 Q3 | 24.25 Million USD | -55.76% |
| 2021 Q4 | 27.83 Million USD | 0.0% |
| 2021 Q3 | 27.83 Million USD | 15.13% |
| 2021 Q2 | 24.18 Million USD | 0.0% |
| 2021 Q1 | 24.18 Million USD | 5.89% |
| 2021 FY | 104.03 Million USD | 16.82% |
| 2020 Q2 | 21.69 Million USD | -0.0% |
| 2020 FY | 89.06 Million USD | 11.85% |
| 2020 Q4 | 22.83 Million USD | 0.0% |
| 2020 Q3 | 22.83 Million USD | 5.26% |
| 2020 Q1 | 21.69 Million USD | 29.7% |
| 2019 Q1 | 23.08 Million USD | 0.0% |
| 2019 Q4 | 16.72 Million USD | 0.0% |
| 2019 Q3 | 16.72 Million USD | -27.55% |
| 2019 Q2 | 23.08 Million USD | 0.0% |
| 2019 FY | 79.62 Million USD | 5.18% |
| 2018 FY | 75.7 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -0.482% |
| AngioDynamics, Inc. | 303.91 Million USD | 68.051% |
| AtriCure, Inc. | 399.24 Million USD | 75.679% |
| Avinger, Inc. | 7.65 Million USD | -1168.935% |
| Azenta, Inc. | 665.07 Million USD | 85.4% |
| BioLife Solutions, Inc. | 143.27 Million USD | 32.227% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 97.298% |
| Daxor Corporation | 1.28 Million USD | -7482.802% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -431.205% |
| Femasys Inc. | 1.07 Million USD | -8957.988% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 13.498% |
| Hologic, Inc. | 4.03 Billion USD | 97.591% |
| ICU Medical, Inc. | 2.25 Billion USD | 95.702% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 98.637% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -240.487% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 49.816% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -8325.222% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -8325.222% |
| Masimo Corporation | 2.04 Billion USD | 95.259% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 92.278% |
| Nephros, Inc. | 14.23 Million USD | -581.97% |
| NovoCure Limited | 509.33 Million USD | 80.936% |
| NEXGEL, Inc. | 4.08 Million USD | -2274.637% |
| NEXGEL, Inc. | 4.08 Million USD | -2274.637% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -3235.586% |
| OraSure Technologies, Inc. | 405.47 Million USD | 76.053% |
| Pro-Dex, Inc. | 53.84 Million USD | -80.334% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -5354.71% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -408.256% |
| QuidelOrtho Corporation | 2.99 Billion USD | 96.761% |
| Repligen Corporation | 638.76 Million USD | 84.799% |
| Sanara MedTech Inc. | 64.98 Million USD | -49.406% |
| STAAR Surgical Company | 322.41 Million USD | 69.884% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -93.332% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 97.551% |
| Jin Medical International Ltd. | 19.82 Million USD | -389.868% |